Home/Filings/4/0000950138-18-000703
4//SEC Filing

Queller David A 4

Accession 0000950138-18-000703

CIK 0001532063other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 5:38 PM ET

Size

17.5 KB

Accession

0000950138-18-000703

Insider Transaction Report

Form 4
Period: 2018-12-20
Queller David A
Sr. VP, Sales and Account Mgmt
Transactions
  • Disposition to Issuer

    Common Stock

    2018-12-2052,7990 total
  • Disposition to Issuer

    Non-Qualified Stock Option (Right to Buy)

    2018-12-2029,5990 total
    Exercise: $74.65Exp: 2021-09-09Express Scripts Holding Company Common Stock (29,599 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (Right to Buy)

    2018-12-2032,3340 total
    Exercise: $84.83Exp: 2025-03-04Express Scripts Holding Company Common Stock (32,334 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (Right to Buy)

    2018-12-2053,6090 total
    Exercise: $69.57Exp: 2026-03-09Express Scripts Holding Company Common Stock (53,609 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (Right to Buy)

    2018-12-2051,9800 total
    Exercise: $67.62Exp: 2027-03-08Express Scripts Holding Company Common Stock (51,980 underlying)
  • Disposition to Issuer

    Phantom Stock Units

    2018-12-20729.020 total
    Exercise: $0.00Express Scripts Holding Company Common Stock (729.02 underlying)
Footnotes (7)
  • [F1]Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the "Merger"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a unit with respect to common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
  • [F2]The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted.
  • [F3]Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
  • [F4]Phantom Stock Unit credited under the Company's Executive Deferred Compensation Plan.
  • [F5]Upon distribution, each phantom stock unit would have converted into one share of the Issuer's common stock.
  • [F6]Pursuant to the Merger Agreement, upon closing of the Merger, each phantom stock unit was converted into a stock unit relating to the common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
  • [F7]Basic Company Credit by the Issuer to Reporting Person's Account in the Executive Deferred Compensation Plan; shares vest 3 (three) years after the plan year to which such credit relates.

Issuer

Express Scripts Holding Co.

CIK 0001532063

Entity typeother

Related Parties

1
  • filerCIK 0001613735

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 5:38 PM ET
Size
17.5 KB